May 04, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) and collaboration partner Celltrion Healthcare announce the commercial availability of Truxima (rituximab-abbs), a biosimilar to Roche's (OTCQX:RHHBY) Rituxa
Sep 02, 2020 - One week ago, the DOJ charged Teva for overcharging customers in an alleged price-fixing conspiracy. In this article, I will take a closer look at what this lawsuit means for Teva.
Mar 18, 2020 -
Mar 26, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session.
Apr 28, 2020 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $10.84, marking a +1.12% move from the previous day.
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
Apr 07, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day.
Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
Sep 11, 2020 - Satsuma (STSA) tanks as late-stage study of STS101 (dihydroergotamine [DHE] nasal) powder as an acute treatment for migraine disappoints.